MedTrace Logo

Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent

NCT00960908 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2009-08-18

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and long-term effectiveness of coronary stenting with the zotarolimus eluting stent (ZES) and to determine clinical device and procedural success during commercial use of ZES.

The investigators will compare 2nd generation ZE (Endeavor resolute, active prospective arm) with 1st generation ZES (Endeavor Sprint, retrospective arm).

Conditions

Interventions

DEVICE

Endeavor Resolute stents

2nd generation ZES

DEVICE

Endeavor Sprint stent

1st generation ZES

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hyo-Soo Kim, MD, PhD · Seoul National University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00960908 on ClinicalTrials.gov